Daily cannabis news
po.tc tracks the practical cannabis stories that shape operators, investors, regulators, and suppliers: medical access, licensing, imports, tax exposure, retail structure, and the policy decisions behind them.
Official forecasts show German cannabis production rising sharply in 2026, yet regulator data indicate that Europe’s biggest medical market will remain dependent on foreign supply.
A final rule effective April 23 moved FDA-approved marijuana products and marijuana handled under qualifying state medical licenses into Schedule III, removing federal 280E tax drag for medical operators while adult-use businesses remain in Schedule I pending a summer DEA hearing.
Full stream
Germany’s official cannabis production estimate for 2026 has risen to 13,700 kilograms. The comparable estimate for 2025 was 2,360 kilograms. That is a near sixfold increase in one year, based on International Narcotics Control...
Read moreThe federal government has split the cannabis market.
Read more